|
|
||||||||
1 Perinatal Research Centre, Departments of Obstetrics/Gynaecology and Physiology, University of Alberta, Edmonton, Alberta T6G 2S2; and 2 Department of Pharmacology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
The
vasodilator effects of thrombin depend on activation of
proteinase-activated receptor (PAR)-1 and the subsequent release of
endothelin (ET)-1, which stimulates the generation of nitric oxide and
PGs. We recently showed that thrombin released matrix metalloproteinase-2 (MMP-2) from rat arteries. We have now studied the
significance of this release for the vasodilator effects of thrombin.
Thrombin (
100 pmol), but not a PAR-1-activating peptide (TFLLR-NH2), produced a long-lasting (>10 min)
vasorelaxation of rat mesenteric arteries, as detected by a
microperfusion bioassay. Thrombin induced a simultaneous release of
vascular MMP-2 into arterial perfusates, as revealed by zymography.
Interestingly, the vasodilator effects of thrombin were inhibited by a
tissue inhibitor of MMP-2 (TIMP-2, 10 pmol). Moreover, infusion of
exogenous MMP-2 (5 pmol) resulted in vasorelaxation. These vasodilatory effects of thrombin and MMP-2 were significantly (P < 0.05)
inhibited by endothelium denudation and by PD-142893 (2 nmol), an
antagonist of ET receptors. Furthermore, both thrombin and MMP-2
constricted endothelium-denuded arteries. These results show that the
vasodilator effects of thrombin may depend, in part, on a release of
vascular MMP-2 and downstream activation of ETs. Thus MMP-2-dependent
signaling may complement the PAR-1-dependent pathway of vasodilator
action of thrombin.
endothelin; vascular; injury; nitric oxide; prostaglandins
This article has been cited by other articles:
![]() |
S. W. Watts, C. Rondelli, K. Thakali, X. Li, B. Uhal, M. H. Pervaiz, R. E. Watson, and G. D. Fink Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2438 - H2448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Z. He, A. Quan, Y. Xu, H. Teoh, G. Wang, J. E. Fish, B. M. Steer, S. Itohara, P. A. Marsden, S. T. Davidge, et al. Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H684 - H693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeyabalan, L. J. Kerchner, M. C. Fisher, J. T. McGuane, K. D. Doty, and K. P. Conrad Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats J Appl Physiol, June 1, 2006; 100(6): 1955 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy Reproductive Sciences, October 1, 2004; 11(7): 438 - 448. [Abstract] [PDF] |
||||
![]() |
K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawabata, S. Kubo, Y. Nakaya, T. Ishiki, R. Kuroda, F. Sekiguchi, N. Kawao, and H. Nishikawa Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery Cardiovasc Res, March 1, 2004; 61(4): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, R. P. Brandes, W. Muller-Esterl, R. Busse, and I. Fleming Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells Circ. Res., January 9, 2004; 94(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fernandez-Patron, K. G. Stewart, Y. Zhang, E. Koivunen, M. W. Radomski, and S. T. Davidge Vascular Matrix Metalloproteinase-2-Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction Circ. Res., October 13, 2000; 87(8): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |